Together Pharma Ltd
TGPHF
Other OTC0.09
USD
- -
- -
Together Pharma Ltd
TGPHF
(Other OTC)
Recent
price
0.09
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Together Pharma Ltd (TGPHF) develops and commercializes innovative pharmaceutical products focused on women's health, dermatology, and gastroenterology. The company offers a portfolio of branded generics and proprietary formulations, including oral contraceptives such as Together Daily and Together 28, topical dermatological treatments for acne and psoriasis, and gastrointestinal therapies like proton pump inhibitors and probiotics; it also provides over-the-counter supplements targeting hormonal balance and skin care. Founded in 2018 and headquartered in Tel Aviv, Israel, Together Pharma operates primarily in Israel and expands into European and North American markets through distribution partnerships. In late 2024, the company secured a $25 million Series B funding round led by U.S. and Israeli venture firms to accelerate U.S. market entry and R&D for novel hormone therapies. Additionally, Together Pharma announced a strategic alliance with a leading European generics manufacturer in early 2025 for co-development of biosimilar injectables and expanded its product pipeline with the launch of a new line of microbiome-based women's wellness products. The company targets healthcare providers, pharmacies, and direct-to-consumer channels in regulated markets, positioning itself as a nimble player in the competitive generics and specialty pharma segments.